Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Magnesium citrate cathartics III SEP / 98
Magnesium glutamate hydrobromideF1 I SEP / 98
Magnesium salicylate except oral dosage forms which also contain choline salicylate III SEP / 98
Magnesium sulfate for parenteral use II SEP / 98
Magnesium sulfate in injectable form for parenteral nutrition I JAN / 03
Manganese and its salts in injectable form for parenteral nutrition I JAN / 03
Mannitol and its salts II SEP / 98
Maprotiline and its saltsF1 I SEP / 98
MaravirocF1 I MAY / 09
Marbofloxacin and its salts and derivativesF1 I MAR / 01
Maropitant or its saltsPDL I DEC / 13
Mazindol and its saltsTS I SEP / 98
Measles vaccine II DEC / 98
MebendazoleF2 I SEP / 98
MebolazineC3 I JUN / 02
Mecamylamine and its saltsF1 I SEP / 98
Mechlorethamine and its saltsF1 I SEP / 98
Meclizine and its saltsF2

when sold in concentrations greater than 25 mg per dosage unit

I JUL / 00
Meclizine and its salts.

when sold in concentrations of 25 mg or less per dosage unit

III MAY / 00
Meclofenamic acid and its saltsF1 I SEP / 98
Mecloqualone and any salt thereofC5 I JAN / 03
MedazepamTS I JUN / 02
Medetomidine and its saltsF1 I MAY / 04
Mefenamic acid and its saltsF1 I SEP / 98
MefenorexTS I JUN / 02
Mefloquine and its salts and derivativesF1 I SEP / 98
Megestrol and its saltsF1 I SEP / 98
Melanoma therapeutic vaccineF1 I MAR / 01
Melarsomine and its saltsF1 when sold for the treatment of heartworm in dogs I MAY / 04
Meloxicam and its salts and derivativesF1 I OCT / 03
MelphalanF1 I SEP / 98
Memantine and its saltsF1 I SEP / 06
Meningococcus vaccine II MAR / 01
MenotropinsF1 human I SEP / 98
Mepacrine and its saltsF1 I SEP / 98
Mepazine and its saltsF1 I SEP / 98
MephenoxaloneF1 I SEP / 98
Mephentermine and its saltsF1 I SEP / 98
MephobarbitalC2 I JUN / 02
Mepivacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Mepivacaine and its salts for ophthalmic or parenteral use II SEP / 98
MepolizumabPDL I AUG / 16
MeprobamateTS I SEP / 98
Mepyramine see pyrilamine U
MercaptopurineF1 I SEP / 98
Meropenem or its salts or derivativesPDL

including but not limited to doripenem

I DEC / 13
MesaboloneC3 I JUN / 02
MesnaF1 I SEP / 98
Mesocarb and any salt thereofC4 I JAN / 03
Mesoridazine and its saltsF1 I SEP / 98
MesteroloneC3 I JUN / 02
MetaldehydeF1 I SEP / 98
MetandienoneC3 I JUN / 02
Metaraminol bitartrate I SEP / 98
Metathoheptazine and its salts II SEP / 98
MetazocineN I JUN / 02
MetenoloneC3 I JUN / 02
Metformin and its salts and derivativesF1 I SEP / 98
MethabarbitalC2 I JUN / 02
Methacholine and its saltsF1 I SEP / 98
MethadoneN I JUN / 02
MethamphetamineC1 I JUN / 02
MethandriolC3 I JUN / 02
Methantheline and its salts II SEP / 98
MethaqualoneC1 I JUN / 02
Methazolamide and its saltsF1 I MAY / 00
Methdilazine and its salts II SEP / 98
Methenamine and its salts except for topical use II SEP / 98
Metheptazine and its salts II SEP / 98
MethimazoleF1 I SEP / 98
MethisazoneF1 I SEP / 98
Methocarbamol for parenteral use II SEP / 98
Methocarbamol. except for parenteral use III SEP / 98
MethoinF1 Mephenytoin and its salts I SEP / 98
Methotrexate and its saltsF1 I SEP / 98
Methotrimeprazine and its saltsF1 I SEP / 98
Methoxamine and its saltsF1 I SEP / 98
MethoxsalenF1 I SEP / 98
Methoxy polyethylene glycol-epoetin betaF1 I OCT / 09
Methyl salicylate in liquid dosage forms in concentrations greater than 30% II SEP / 98
Methyl salicylate. in liquid dosage forms in concentrations up to and including 30% U
MethyldesorphineN I JUN / 02
MethyldihydromorphineN I JUN / 02
Methyldopa and its saltsF1 I SEP / 98
Methylene Blue for parenteral use II SEP / 98
MethylparafynolF1 I SEP / 98
MethylphenidateC1 I JUN / 02
MethylphenobarbitalC2 I JUN / 02
MethylphenylisonipecotonitrileN I JUN / 02
MethyltestosteroneC3 I JUN / 02
MethyprylonTS I SEP / 98
Methysergide and its salts and derivativesF1 I SEP / 98
MetoclopramideF1 I SEP / 98
Metolazone and its saltsF1 I SEP / 98
Metomidate and its saltsF1 I SEP / 98
Metopimazine and its saltsF1 I SEP / 98
MetoponN I JUN / 02
Metoprolol and its saltsF1 I SEP / 98
MetriboloneC3 I JUN / 02
MetronidazoleF1 I SEP / 98

140 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled